ProCE Banner Activity

Hidradenitis Suppurativa: Improving Outcomes With Early Screening and Novel Treatments

Clinical Thought

For advanced practice providers, learn strategies for screening patients for hidradenitis suppurative and associated comorbidities, as well as how to implement novel therapies to improve patient outcomes and quality of life.

Released: April 22, 2025

Expiration: April 21, 2026

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners), in collaboration with the Coalition of Skin Diseases (CSD)

ProCE Banner

Supporters

Supported by an educational grant from Incyte.

Incyte

Partners

Coalition of Skin Diseases (CSD)

ProCE Banner

Disclosure

Primary Author

Amit Garg, MD: consultant/advisor/speaker: AbbVie, Almirall, Boehringer Ingelheim, Engitix, Immunitas, Incyte, Insmed, Novartis, Pfizer, Sonoma, Sun Pharma, UCB, Union Therapeutics, Zura Bio.